CAS: 2143096-93-7
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Navitoclax-piperazine REF: TM-T12186CAS: 2143096-93-7 | 99.82% | 153.00 €~1,500.00 € | Mon 13 May 24 | |
Navitoclax-piperazine REF: 3D-TKD09693CAS: 2143096-93-7 | Min. 95% | 298.00 €~1,275.00 € | Tue 25 Jun 24 |
Navitoclax-piperazine
CAS:2143096-93-7
Navitoclax-piperazine (ABT-263-piperazine) is an inhibitor of B-cell lymphoma extra large (BCL-XL).
Formula:
C47H56ClF3N6O5S3
Purity:
99.82%
Color and Shape:
Solid
Molecular weight:
973.63
Ref: TM-T12186
1mg | 153.00 € | |
5mg | 302.00 € | |
10mg | 513.00 € | |
25mg | 809.00 € | |
50mg | 1,111.00 € | |
100mg | 1,500.00 € | |
1ml*10 (DMSO) | 523.00 € |
Estimated delivery in United States, on Monday 13 May 2024
Navitoclax-piperazine
CAS:2143096-93-7
Navitoclax-piperazine is a cell biology research tool that inhibits protein interactions. It is a small …
Formula:
C47H56ClF3N6O5S3
Purity:
Min. 95%
Molecular weight:
973.6 g/mol
Ref: 3D-TKD09693
1mg | 298.00 € | |
2mg | 399.00 € | |
5mg | 569.00 € | |
10mg | 847.00 € | |
25mg | 1,275.00 € |
Estimated delivery in United States, on Tuesday 25 Jun 2024